Article Sidebar

PDF
Date Published: 21/06/2022
Abstract Views: 511
Views PDF: 360
DOI: https://doi.org/10.51298/vmj.v514i2.2649
Issue
Vol. 514 No. 2 (2022)
Section
Các bài báo
How to Cite
Huy Tuấn Kiệt, P. ., Văn Giáp, V. ., & Thị Thanh Hà, N. . (2022). DIRECT MEDICAL COST OF CHRONIC OBSTRUCTIVE LUNG DISEASE MANAGEMENT IN VIETNAM FOLLOWING CLASSIFCATION OF GOLD BASED ON BIG DATA ANALYSIS OF NATIONAL SOCIAL HEALTH INSURANCE DATABASE IN 2020. Vietnam Medical Journal, 514(2). https://doi.org/10.51298/vmj.v514i2.2649

DIRECT MEDICAL COST OF CHRONIC OBSTRUCTIVE LUNG DISEASE MANAGEMENT IN VIETNAM FOLLOWING CLASSIFCATION OF GOLD BASED ON BIG DATA ANALYSIS OF NATIONAL SOCIAL HEALTH INSURANCE DATABASE IN 2020

Phạm Huy Tuấn Kiệt1,, Vũ Văn Giáp1, Nguyễn Thị Thanh Hà2
1 Hanoi Medical University
2 Vietnam Social Security

Main Article Content

Abstract

Objective: To evaluate the direct medical cost of chronic obstructive lung disease (COPD) management following classifcation of GOLD (Global Initiative for Chronic Obstructive Lung Disease) based on big data analysis of national Social Health Insurance database in 2020. Methods: A descriptive cross-sectional study was conducted to calculate direct medical cost of COPD patients classified by GOLD. Results: Annual average direct medical costs per patient in GOLD classified A, B, C and D were 3.1; 4.6; 12.2; and 58.6 million VND, respectively. Total economic burden of patients in GOLD classified A, B, C and D were 321.026.108.935, 326.829.474.623, 1.852.691.299.408 and 52.479.725.849 VND. Medication cost accounted for a significant proportion in the cost of treatment. Conclusion: The results of study provided information about the economic burden of COPD treatment in Vietnam. Measures to improve COPD management in the early stage can prevent progressing to the late stage and decrease the economic burden of COPD in Vietnam.

Article Details

Keywords

Direct medical cost, Social Health Insurance, Economic Burden, Chronic Obstructive Lung Disease

References

1. GOLD 2020, Global Strategy For The Diagnosis, Management, And Prevention Of Chronic Obstructive Pulmonary Disease. 2020.
2. Nhung, N.V. and Sy, D.N., National prevalence survey of chronic obstructive pulmonary disease in Viet Nam. 42nd Union World Congress on Lung Health. 2011.
3. Løkke, A., et al., Economic Burden of COPD by Disease Severity – A Nationwide Cohort Study in Denmark. Int J Chron Obstruct Pulmon Dis. 2021; 16: p.603-613.
4. Hau, L.T. and Ha, N.T., Chi phí điều trị trực tiếp Bệnh phổi tắc nghẽn mạn tính từ góc độ bảo hiểm y tế, hộ gia đình và một số yếu tố liên quan tại khoa Bệnh phổi mạn tính, Bệnh viện Phổi Trung ương năm 2019. Tạp chí Khoa học Nghiên cứu Sức khỏe và Phát triển 2019; 04(03).
5. Stafyla, E., et al., The annual direct costs of stable COPD in Greece. Int J Chron Obstruct Pulmon Dis. 2018; 13: p.309-315.
6. Chau, N.Q., et al., Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam. Int J Environ Res Public Health 2018; 16(1): p.88.